Z17.410
Hormone receptor positive with human epidermal growth factor receptor 2 positive status
Clinical Classification Guidelines
Inclusion Terms
- HR+ with HER2+
Medical Intelligence & Overview
ICD-10 code Z17.410 refers to a subtype of breast cancer characterized by the presence of hormone receptors and overexpression of the human epidermal growth factor receptor 2 (HER2). This specific profile of breast cancer influences how the disease progresses and determines the most effective treatment options. Hormone receptor-positive and HER2-positive breast cancers are unique in how they grow and respond to therapies, making accurate diagnosis and tailored treatment plans essential for optimal patient outcomes.
Causes & Symptoms
Clinical Causes: Genetic mutations that alter cell growth and division Inherited gene changes passed down from family members Environmental factors such as radiation exposure Hormonal influences, particularly estrogen and progesterone levels Overexpression of the HER2 gene, leading to increased cell proliferation
Key Symptoms: Lumps in the breast or underarm area Unexplained changes in the size, shape, or appearance of the breast Persistent pain in the breast or nipple Nipple discharge that is not milk Skin changes on the breast, such as redness or dimpling Swelling or a mass that can be felt during self-examination
Diagnostic & Treatment
Diagnosis Path: The diagnosis of hormone receptor-positive and HER2-positive breast cancer involves several steps:
Treatment Protocols: Treatment approaches for this breast cancer subtype are tailored based on the tumor characteristics and patient health. Common strategies include:
Clinical Advice & FAQs
Billing Guidance
Is Z17.410 a billable ICD-10 code?
Yes, Z17.410 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z17.410?
Clinical documentation must specify the nature of Hormone receptor positive with human epidermal growth factor receptor 2 positive status and any associated comorbidities for accurate reporting.
Cite this Clinical Reference